Smith & Nephew plc has announced its results for the second quarter ended 29 June 2013 and the revenue growth … continue reading “Smith & Nephew Results Hold Up Despite Joint Pain”
Orthopaedics
FDA Clears Integra’s Titan™ Reverse Shoulder System
Integra LifeSciences Holdings Corporation has announced that the Integra® Titan™ Reverse Shoulder System has received 510k clearance from the U.S. FDA. … continue reading “FDA Clears Integra’s Titan™ Reverse Shoulder System”
Stryker Takes the Pain, But Underlying Picture Looks Pretty Strong
If it’s true that Stryker has suffered from downward pricing pressure, foreign exchange pressure and absorbed recall costs this quarter, it’s perhaps not surprising they sound a bit pessimistic. But restructuring, acquisitions and positive mix changes suggest it’s not all that bad.
Dallen Medical Files Syndesmosis Tensyn™ Band 510(k)
Dallen Medical has announced that it has submitted an FDA 510(k) application as it seeks clearance for its proprietary Tensyn™ Band for syndesmosis repair.
New Ceterix Meniscal Stitcher: Clever, But Is It Perfect?
Ceterix™ Orthopaedics, Inc. has announced the commercial availability of its NovoStitch™ suture passer in the United States. The device enables surgeons to place stitches in tight joint compartments, including those in knees, hips and shoulders, during minimally invasive arthroscopic surgical procedures.
Mitek’s New Cuff Anchor Launched At AOSSM 2013
It’s sports med week this week, with the annual gathering that is the AOSSM meeting taking place in Chicago. Mitek Sports Medicine, a DePuy Synthes Company, under the wing of Johnson & Johnson, has used the event to showcase its new HEALIX ADVANCE™ KNOTLESS Anchor, a new suture anchor it says is designed to provide optimal knotless fixation for rotator cuff repair.
Aircast Ankle Brace Supports Murray In Wimbledon Win
Who knows whether the headline is true or not. Indeed DJ Orthopedics, with its Aircast, has not done much to … continue reading “Aircast Ankle Brace Supports Murray In Wimbledon Win”
CE Mark For Episurf’s Episealer® Customised Cartilage Replacement Device
Stockholm based Episurf Medical has gained CE Mark certification for its personalised Episealer® implant for the treatment of femoral condyle cartilage defects in the knee.
Orthofix Launches Trinity® ELITE™ Moldable Bone Graft
Orthofix International N.V., in collaboration with the Musculoskeletal Transplant Foundation (MTF), has announced the full market release of Trinity® ELITE™ … continue reading “Orthofix Launches Trinity® ELITE™ Moldable Bone Graft”
First UK Evaluation of Continuous Targeted Brain Cooling In Cardiac Arrest From Street To ITU
For the first time in the UK, the RhinoChill® IntraNasal Cooling System is being jointly evaluated by an ambulance service … continue reading “First UK Evaluation of Continuous Targeted Brain Cooling In Cardiac Arrest From Street To ITU”
Study Will Assess Whether Autologous Stem Cells Promote Healing of Knee Cartilage
Cell-technology company InGeneron, Inc., has announced a study to assess the use of adult adipose derived regenerative cells to enhance cartilage healing after knee surgery. The study will utilize InGeneron’s patented Transpose RT™ system to prepare regenerative cells from the patient’s own fat tissue.
STAR™ Total Ankle Replacement Passes 5,000 Implant Milestone In The US
Small Bone Innovations, Inc. has announced that surgeons in the US have now implanted more than 5,000 STAR Total Ankle Replacement Systems since receiving FDA approval in May 2009.
Wright’s OrthoRecon Business Divestiture Reinforces Its Extremity Focus
Transaction Transforms Wright Medical into High Growth Extremities and Biologics Pure Play and Expands Growth Opportunities for OrthoRecon Business
Purchase Price of $290 Million Cash
Range Filler Filler: FDA 510(k) Clears Abyrx,™ Absorbable Hemostatic Bone Putty
Abyrx, Inc., a privately-held therapeutic device company, has announced the US FDA Clearance of its new Absorbable Hemostatic Bone Putty (AHBP) for clinical use in the country. The company says this is new product shows it’s offering a vertically integrated product strategy.
FDA Clears Verasense™ Knee System To Optimise Joint Replacement Outcome
FDA clearance for Verasense means it’s the first intraoperative system to market that combines quantifiable limb alignment and soft tissue balancing for surgeons during total knee arthroplasty.
FDA Clears Absorbable Hemostatic Bone Putty From Abyrx,™Inc.
Newly cleared AHBP is ready-to-use and achieves hemostasis by mechanical tamponade. Its proprietary formulation is comprised of water soluble and dispersible components that are fully synthetic and substantially absorb within days following surgery.